Marie McDonald
Fortune : 628 038 $ au 31/07/2026
Fortune : 628 038 $ au 31/07/2026
Currently, Marie McDonald is an Independent Non-Executive Director at Nanosonics Ltd. since 2016, a Non-Executive Director at The Walter & Eliza Hall Institute of Medical Research since 2016, an Independent Non-Executive Director at Nufarm Ltd. since 2017, a Director at The Melbourne University Law School Foundation since 2021, and an Independent Non-Executive Director at Telix Pharmaceuticals Ltd. starting in 2025.
Formerly, the roles include Independent Non-Executive Director at CSL Ltd., Member of the Australia Takeovers Panel from 2001 to 2010, National Head-Mergers & Acquisitions at Law Council of Australia Ltd. from 2012 to 2013, and Senior Partner at Ashurst Australia from 1990 to 2014.
Education was completed at the University of Melbourne with undergraduate and graduate degrees.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CSL LIMITED 0 % | 29/08/2025 | 4 457 ( 0 % ) | 385 224 $ | 31/07/2026 |
NANOSONICS LIMITED 0,02 % | 30/06/2025 | 50 106 ( 0,02 % ) | 110 503 $ | 31/07/2026 |
NUFARM LIMITED 0,01 % | 30/09/2025 | 45 179 ( 0,01 % ) | 95 194 $ | 31/07/2026 |
| 26/05/2026 | 3 719 ( 0 % ) | 37 117 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NANOSONICS LIMITED | Directeur/Membre du Conseil | 24/10/2016 |
| NUFARM LIMITED | Directeur/Membre du Conseil | 22/03/2017 |
| TELIX PHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | 03/03/2025 |
The Walter & Eliza Hall Institute of Medical Research
The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Directeur/Membre du Conseil | 01/10/2016 |
The Melbourne University Law School Foundation | Directeur/Membre du Conseil | 01/10/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Ashurst Australia
Ashurst Australia Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/07/2014 |
Law Council of Australia Ltd.
Law Council of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Operates law firms | Corporate Officer/Principal | 01/01/2013 |
Australia Takeovers Panel
Australia Takeovers Panel General GovernmentGovernment Resolves disputes about a takeover bid until the bid period has ended | Corporate Officer/Principal | 01/01/2010 |
| CSL LIMITED | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Australia Takeovers Panel
Australia Takeovers Panel General GovernmentGovernment Resolves disputes about a takeover bid until the bid period has ended | Government |
Nanosonics Ltd.
Nanosonics Ltd. Medical SpecialtiesHealth Technology Engages in the research, development and commercialization of infection control and decontamination products and related technologies | Health Technology |
The Walter & Eliza Hall Institute of Medical Research
The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Nufarm Ltd.
Nufarm Ltd. Chemicals: AgriculturalProcess Industries Manufactures and markets agricultural crop protection products | Process Industries |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Law Council of Australia Ltd.
Law Council of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Operates law firms | Commercial Services |
Ashurst Australia
Ashurst Australia Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The Melbourne University Law School Foundation | |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national